Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
White Matter Injury in Ischemic Stroke.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Inhibin-a immunoreactivity in nervous system lesions.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
Pages
« first
‹ previous
…
712
713
714
715
716
717
718
719
720
…
next ›
last »